SCHEMBL29384148

SCHEMBL29384148

C[C@H](N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ACE P12821 10/20 0.49
REN P00797 4/20 0.49
KDM4E B2RXH2 1/20 0.49
F2 P00734 1/20 0.49
LMNA P02545 1/20 0.49
LTA4H P09960 1/20 0.49
MAPT P10636 1/20 0.49
PEPD P12955 1/20 0.49
ALOX15 P16050 1/20 0.49
PTGS1 P23219 1/20 0.49
HTR2A P28223 1/20 0.49
PTGS2 P35354 1/20 0.49
HRH1 P35367 1/20 0.49
THPO P40225 1/20 0.49
PMP22 Q01453 1/20 0.49
HSD17B10 Q99714 1/20 0.49
ACE2 Q9BYF1 1/20 0.49
XPNPEP2 O43895 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2549572 0.95 ACE (0.54) ACERENKDM4EF2LMNA
SCHEMBL6559375 0.95 ACE (0.54) ACERENKDM4EF2LMNA
SCHEMBL30140016 0.92 ACE (0.51) ACERENKDM4EF2LMNA
SCHEMBL29409186 0.88 ACE (0.47) ACERENKDM4EF2LMNA
SCHEMBL29378104 0.88 ACE (0.47) ACERENKDM4EF2LMNA
SCHEMBL29836001 0.86 ACE (0.46) ACERENKDM4EF2LMNA
SCHEMBL10654681 0.85 PREP (0.57) ACERENKDM4EF2LMNA
SCHEMBL10658601 0.85 ACE (0.57) ACERENKDM4EF2LMNA
SCHEMBL31401997 0.85 ACE (0.57) ACERENKDM4EF2LMNA
SCHEMBL30139015 0.85 ACE (0.57) ACERENKDM4EF2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118675647-A Method, apparatus, device and medium for merging large-scale drug data lists 慧算基因科技(上海)有限公司 2024-09-20 CN claimed
CN-114674583-A Intelligent sweeping robot test evaluation method based on household application scene 威凯检测技术有限公司 2022-06-28 CN claimed
WO-2022034180-A1 METHOD AND CONTROL APPARATUS FOR OPERATING A TANK VENTILATION SYSTEM OF AN INTERNAL COMBUSTION ENGINE Vitesco Technologies GmbH (DE) 2022-02-17 WO claimed
US-20260146063-A1 CYCLIC CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF OHIO STATE INNOVATION FOUNDATION (US) 2026-05-28 US disclosed
WO-2026107178-A1 GLOBAL AFFINITY PROFILING OF MOLECULAR INTERACTIONS USING COMPETITIVE ENRICHMENT CORNELL UNIVERSITY (US) 2026-05-21 WO disclosed
WO-2026101234-A1 PHOTOCATALYST COMPRISING METHANE MONOOXYGENASE HYDROXYLASE AND XANTHENE-BASED PHOTO HARVESTER 건국대학교 산학협력단 2026-05-15 WO disclosed
US-20260125696-A1 EFFICIENT INDUCTION OF PARTHENOGENESIS IN CROP PLANTS UNIV CALIFORNIA (US) 2026-05-07 US disclosed
WO-2026086535-A1 METHOD AND APPARATUS FOR DETERMINING MOTION STATE OF OBJECT, AND VEHICLE 深圳引望智能技术有限公司 2026-04-30 WO disclosed
EP-4727545-A2 COMBINATION TREATMENTS FOR DEPRESSION AND OTHER DISORDERS Neurawell Therapeutics (US) 2026-04-22 EP disclosed
EP-4729163-A1 METHOD FOR PRODUCING DISPERSION COMPOSITION artience Co., Ltd. (JP) 2026-04-22 EP disclosed
EP-4418110-B1 APPLICATION LAUNCH METHOD, APPLICATION LAUNCH SYSTEM, STORAGE MEDIUM, AND INTELLIGENT TERMINAL NIO TECHNOLOGY ANHUI CO LTD (CN) 2026-04-08 EP disclosed
CN-112458072-B Alkaline protease mutant and preparation thereof 山东隆科特酶制剂有限公司 2022-04-08 CN disclosed
CN-114298683-A Computer system integrated technical service system 睿丰自动化科技海门有限公司 2022-04-08 CN disclosed
EP-3969041-A2 COMPOSITIONS AND METHODS FOR TREATING T CELL EXHAUSTION Taiga Biotechnologies, Inc. (US) 2022-03-23 EP disclosed
CN-114207108-A Genetically modified host cells producing glycosylated cannabinoids 奥克塔林生物制剂公司 2022-03-18 CN disclosed
EP-3965825-A1 COMPOSITIONS AND METHODS TO MANUFACTURE PHOSPHATASE AND TENSIN HOMOLOG (PTEN) FUSIONS Therapten Biosciences Inc. (CA) 2022-03-16 EP disclosed
US-20220066906-A1 APPLICATION STATE PREDICTION USING COMPONENT STATE BMC HELIX, INC. 2022-03-03 US disclosed
US-11259074-B2 Information processing device, and information processing method, and program SONY CORPORATION (JP) 2022-02-22 US disclosed
WO-2022034180-A1 METHOD AND CONTROL APPARATUS FOR OPERATING A TANK VENTILATION SYSTEM OF AN INTERNAL COMBUSTION ENGINE Vitesco Technologies GmbH (DE) 2022-02-17 WO disclosed
WO-2022029477-A1 IMAGE PROCESSING METHOD AND APPARATUS, ELECTRONIC DEVICE, AND STORAGE MEDIUM SENSETIME INTERNATIONAL PTE. LTD. (SG) 2022-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260146063-A1 CYCLIC CELL PENETRATING PEPTIDES AND METHODS OF MAKING AND USING THEREOF VIP, SLC7A1, SLC6A15 ACE 1946/4885REN 1662/4885KDM4E 3490/4885
US-20260125696-A1 EFFICIENT INDUCTION OF PARTHENOGENESIS IN CROP PLANTS BOD1L1, MYB, POF1B ACE 4682/4885REN 4845/4885KDM4E 1962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.